RxDoctor Payments Data

Megan Hershberger, MD

Family Medicine · Massillon, OHNPI 1396240065

Payments from drug & device makers

$8,278in general payments, 2019–2025

Across 482 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$647
  • Lilly USA, LLC$577
  • Pfizer$533
  • Boehringer Ingelheim$476
  • Novo Nordisk$449
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$8,278100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,278 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$55,165
Medicare patients
148
Services billed
1,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$38,809
OzempicSemaglutide27$27,128
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$21,640
JardianceEmpagliflozin17$10,430
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$10,074
Albuterol Sulfate HfaAlbuterol Sulfate103$2,684
Rosuvastatin Calcium238$2,148
Omeprazole193$1,913
Levothyroxine Sodium209$1,817
Duloxetine Hcl52$1,674
Metoprolol Succinate100$1,569
Celecoxib21$1,429
Ipratropium Bromide43$1,323
Atorvastatin Calcium139$1,277
Sertraline Hcl74$1,264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$533$38,80946 claims
Novo NordiskOzempic$449$27,12827 claims
GSKTrelegy Ellipta$328$21,64023 claims
Boehringer IngelheimJardiance$476$10,43017 claims
AstraZenecaBreztri Aerosphere$647$10,07412 claims
Almatica Pharma LLCSertraline Hcl$101$1,26474 claims
AbbVieSynthroid$1,336$41714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Massillon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →